جست‌وجوی استاد و پژوهشگر

Sophie van der Sluisمشاهده پروفایل

استاد مهمان

• Genetics
• Neuroscience
• Psychometrics
• +۳ مورد دیگر

Sophie van der Sluis is a Visiting Professor at the Vrije Universiteit Amsterdam, affiliated with the Faculty of Science’s Department of Complex Trait Genetics and Amsterdam Neuroscience. Her research focuses on genetic determinism, behavioral neuroscience, and molecular mechanisms underlying neurological and psychiatric disorders. Key interests include genome-wide association studies, gene-environment interactions, and translational neurogenetics. Her work contributes to Sustainable Development Goals related to health and well-being (SDG 3). Recent research highlights include studies on schizophrenia risk through genetic overlap with immune development, alcohol misuse influenced by environmental factors, and synaptic dysfunction in neurodevelopmental disorders. She has authored over 90 publications, with a focus on genetic and molecular pathways. Teaches courses in Cognitive Neuroscience, Statistics in Neurosciences, and Nature versus Nurture. Contributed to datasets on hyperarousal mechanisms and insomnia-related temperature regulation. Supervised four PhD theses, though specific advisees are not listed. Labs/Teams: Active in Amsterdam Neuroscience’s Complex Trait Genetics group, collaborating on brain disease modeling and genetic epidemiology.

René Poolمشاهده پروفایل

استادیار

• Metabolomics
• Systems Biology
• Genetics
• +۵ مورد دیگر

Dr. René Pool is an Assistant Professor at the Vrije Universiteit Amsterdam, affiliated with the Faculty of Behavioural and Movement Sciences and Biological Psychology department. He also holds appointments in the APH - Health Behaviors & Chronic Diseases and APH - Personalized Medicine groups. His research focuses on metabolomics, systems biology, and multi-omics data integration, leveraging the Netherlands Twin Register (NTR) dataset. Pool completed his PhD in Computational Physics & Chemistry at the University of Amsterdam and has a background in medicinal chemistry from VU. Key research areas: Metabolomics, epigenetics, genome-wide association studies, and behavioral genetics Teaching: 'Introduction to omics', 'Molecular Genetics' for psychology students His work bridges (bio)chemistry, systems biology, and high-dimensional data analysis to explore biological dysfunction through metabolomics. Recent studies include associations between metabolites and wellbeing, genetic influences on developmental milestones, and epigenetic mechanisms in asthma. Notable collaborations include twin-based Mendelian randomization studies, metabolomic profiling of migraine, and integrative omics approaches for mental health disorders. Pool contributes to the ACTION Consortium and has published over 120 peer-reviewed articles.

• Genetics
• Genomics
• Medical Genetics
• +۳ مورد دیگر

Po-Ru Loh is a Research Fellow at Harvard University's T.H. Chan School of Public Health and affiliated with Brigham and Women's Hospital since 2017. He holds a PhD from the Massachusetts Institute of Technology (2013) and a BS from the California Institute of Technology (2007). His research focuses on genetics, genomics, and their applications to public health, particularly in understanding genetic variation's role in complex diseases and cellular processes like clonal hematopoiesis. Notable work includes studies on somatic mutations, mosaic chromosomal alterations, and the genetic basis of traits such as pigmentation and disease susceptibility. Key research interests include analyzing genetic drivers of cellular selection, interpreting copy number variations, and leveraging genomic data to improve disease risk prediction. He received the Overton Prize in 2022 for his contributions to computational genetics. His recent work highlights advancements in detecting somatic structural variants and integrating haplotype information for enhanced genome-wide association studies. His affiliations span academic and clinical institutions, combining theoretical research with translational efforts. Collaborations leverage large-scale biobank data to uncover genetic mechanisms underlying health disparities and disease risks across diverse populations.

Carol Bultمشاهده پروفایل

استاد

• Bioinformatics
• Developmental Genomics
• Genetic and Genomic Data Integration
• +۴ مورد دیگر

Carol Bult is a Professor affiliated with the Graduate School of Biomedical Science and Engineering at the University of Maine and is a core member of The Jackson Laboratory (JAX). Her research focuses on bioinformatics and developmental genomics. She leads the Mouse Genome Informatics (MGI) consortium, developing databases such as the Mouse Phenome Database to integrate genetic and genomic data for mouse models. Her work supports understanding human diseases through mouse models, including cancer and pulmonary fibrosis. Collaborations include projects with Dr. Isaac Kohane to link lung development to lung diseases via molecular genetics. Key contributions include the MouseCyc biochemical pathway database and integrated mRNA/microRNA profiles in murine lung development. Her research integrates diverse data types, emphasizing translational applications for human health. She maintains active roles in genomic databases critical to biomedical research, ensuring public access to comprehensive mouse genetic resources.

Ashleigh Griffinمشاهده پروفایل

استاد

• Evolutionary Biology
• Social Evolution
• Bacterial Cooperation
• +۲ مورد دیگر

Professor Ashleigh Griffin holds the position of Professor of Evolutionary Biology at the University of Oxford. Her research examines fundamental questions about cooperative behavior evolution across biological systems, from microbial communities to vertebrate societies. Research integrates theoretical frameworks with experimental approaches to understand how cooperation evolves despite inherent conflicts. Current projects investigate: 1) Bacterial social evolution applied to antibiotic resistance and infection dynamics 2) Cooperative breeding systems in birds under environmental variability 3) Conflict resolution mechanisms enabling evolutionary transitions to multicellularity. Laboratory work utilizes Pseudomonas aeruginosa models while field studies analyze cooperative bird species. Publications demonstrate consistent innovation in social evolution theory, spanning microbial cooperation, vertebrate behavioral ecology, and clinical applications. Recent articles reflect expanded focus on environmental variability's role in cooperation, evolutionary medicine approaches to infection treatment, and developmental innovations reducing cellular conflicts. Honors include the 2008 UNESCO/L'Oréal Fellowship for Women in Science, recognizing exceptional contributions to evolutionary biology research.

• Neurobehavioral genetics
• Psychiatric genetics
• Bipolar disorder
• +۷ مورد دیگر

Nelson B. Freimer, MD , is the Maggie G. Gilbert Endowed Chair and Distinguished Professor of Psychiatry and Human Genetics at the University of California, Los Angeles (UCLA). He holds dual appointments as Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences and in the Department of Human Genetics within the David Geffen School of Medicine. Dr. Freimer is the Founding Director of the UCLA Center for Neurobehavioral Genetics and the UCLA Neuroscience Genomics Core, and he leads the university-wide UCLA Depression Grand Challenge (DGC), which aims to cut the global burden of depression in half by 2050. Education : He earned a BA in Anthropology from the University of Pennsylvania in 1978, followed by an MD from Ohio State University in 1982. He completed a Fellowship in Pediatrics at UCSF in 1983, a Psychiatry residency at UCSF in 1987, and a Fellowship in Psychiatry & Genetics at Columbia University in 1990. Research Interests : Dr. Freimer's research focuses on using large-scale genomics and innovative behavioral phenotyping to uncover the genetic basis of complex neurobehavioral disorders, including bipolar disorder, schizophrenia, depression, and Tourette syndrome. He integrates multi-omics approaches (genomics, transcriptomics, metabolomics) with digital phenotyping using smartphones and electronic health records to advance precision psychiatry. His work spans diverse populations, with particular emphasis on Latin American and African ancestries to address global health disparities. Research Trends : His recent publications reveal a convergence of large-scale GWAS, rare variant discovery, and integrative multi-omics analyses to elucidate the biological underpinnings of psychiatric disorders. Studies emphasize cross-disorder genetic overlap, environmental interactions, and the role of synaptic and immune pathways. Digital mental health tools and geospatial epidemiology in Colombia further highlight his commitment to translational and global mental health research. Scientific Awards & Honors : While specific awards are not listed in the provided text, Dr. Freimer holds an endowed chair and distinguished professorship, reflecting significant recognition in his field. Grants & Leadership : He has served as Principal or Co-Principal Investigator on numerous NIH and foundation grants, including: Global Parkinson’s Genetics Program (2024–2025) Impact of COVID-19 on Severe Mental Illness (2023–2026) Genetic Discovery in Latin American and African Ancestries (2020–2025) Latin American Biobank for Mental Illness Genetics (2020–2025) Tourette Syndrome Genetics (2018–2023) UCLA Depression Grand Challenge (ongoing) Labs & Cores : He founded and directs the UCLA Center for Neurobehavioral Genetics and the UCLA Neuroscience Genomics Core, which provide cutting-edge resources for genomics and neurobehavioral research.

Eleazar Eskinمشاهده پروفایل

استاد

• Computational Genomics
• Bioinformatics
• Genetics
• +۵ مورد دیگر

Eleazar Eskin is a Professor at the University of California Los Angeles (UCLA) with appointments in Computer Science , Human Genetics , and Computational Medicine . He is affiliated with the Henry Samueli School of Engineering and Applied Science and contributes to interdisciplinary research bridging computational methods with biomedical applications. PhD in Computer Science, Stanford University Postdoctoral Fellowship, University of Southern California Eskin’s research focuses on computational genomics , statistical genetics , and machine learning applications in medicine . He develops algorithms for genome-wide association studies (GWAS) , structural variant detection , and multi-omics data integration , addressing challenges in population stratification , pleiotropy , and epigenetic regulation . His recent publications span 2023–2025 , emphasizing machine learning in clinical diagnostics , computational reproducibility , and genetic mechanisms in complex traits . Collaborative projects include the GTEx Consortium and UCLA’s Computational Pan-Genomics initiatives. Scientific awards include the NSF CAREER Award , Alfred P. Sloan Fellowship , and NIH Director’s Pioneer Award . He leads NIH-funded programs like R25GM135043 (Computational Genomics Summer Institute) and R25NS115554 (Undergraduate Neurogenomics Training). Eskin mentors trainees through NIH T32 grants and co-developed methods like MARS (allelic heterogeneity), PLEIO (pleiotropy analysis), and BayesCCE (epigenetic modeling). His work impacts SARS-CoV-2 testing , neurodevelopmental disorders , and precision medicine .

• Neurogenetics
• Cerebellar Ataxia
• Spinocerebellar Ataxia
• +۶ مورد دیگر

Brent Linden Fogel is a Professor-in-Residence in both Neurology and Human Genetics at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He directs the UCLA Clinical Neurogenomics Research Center and the UCLA Neurogenetics Clinic, where he focuses on using genomic sequencing to identify rare and novel causes of neurological disease. Dr. Fogel also runs a specialized clinic for patients with Ataxia with Oculomotor Apraxia (AOA) and treats various disorders of balance and coordination at the UCLA Ataxia Center. His educational background includes a PHD in Microbiology & Molecular Genetics (2001) and an MD (2003) from the Medical College of Wisconsin, followed by residency in Medicine at Northwestern (2004), Neurology at UCLA Medical Center (2007), and Neurogenetics fellowship at UCLA Medical Center (2009). Dr. Fogel's research uses genomics, bioinformatics, and systems biology to understand how genetic mutations lead to neurodegenerative disorders such as spinocerebellar ataxia or neurodevelopmental conditions. His work specifically focuses on the molecular pathogenesis of ataxia with oculomotor apraxia (AOA), and he is developing gene therapy approaches to treat this disorder. His research spans gene regulation, RNA processing, and next-generation sequencing analysis. His extensive publication record shows a strong focus on cerebellar ataxias, with particular emphasis on spinocerebellar ataxia types, genetic mechanisms, and diagnostic approaches. Recent work demonstrates increasing integration of genomic and imaging techniques for precision medicine applications, along with development of bioinformatics tools for analyzing complex neurological disorders. Dr. Fogel's research has been funded by the American Academy of Neurology / American Brain Foundation, the National Institutes of Health (including R01NS082094 and K08MH086297), and the National Ataxia Foundation. His work bridges clinical neurology with cutting-edge genomic research to advance diagnosis and treatment of rare neurological disorders.

• Cardiovascular Disease
• Genetics and Genomics
• Metabolism
• +۵ مورد دیگر

Aldons J Lusis is a Professor at the University of California Los Angeles with appointments in Medicine, Human Genetics, and MIMG (Microbiology, Immunology & Molecular Genetics). His research spans multiple disciplines at the intersection of cardiovascular biology, metabolism, and genetics. Dr. Lusis's research focuses on understanding the genetic and molecular mechanisms underlying cardiovascular diseases, particularly atherosclerosis. His work integrates systems genetics approaches to study complex traits, with emphasis on gene-environment interactions, sex differences in disease susceptibility, and the role of the gut microbiome in cardiometabolic disorders. His laboratory employs mouse models, human genetics, and multi-omics analyses to uncover novel pathways in heart disease, metabolic disorders, and tissue repair mechanisms. The trends in Dr. Lusis's recent publications reveal a strong focus on cardiometabolic interactions, with particular attention to sex-specific differences in disease mechanisms. His work spans from basic molecular mechanisms (mitochondrial function, lipid metabolism) to translational applications (therapeutic targets for heart failure, atherosclerosis). A significant portion of his recent work examines the gut-heart axis and how microbial metabolites influence cardiovascular health. Dr. Lusis has established himself as a leader in systems genetics approaches to cardiovascular disease, mentoring numerous students and postdoctoral fellows while securing substantial research funding. His work has been supported by NIH grants, including T32 training programs for graduate students in bioscience. His laboratory is part of UCLA's broader cardiovascular research ecosystem, collaborating with multiple institutes and centers focused on genetics, metabolism, and cardiovascular diseases. The team utilizes advanced genomic, proteomic, and metabolomic approaches to study disease mechanisms across multiple model systems.

Anna Fellerمشاهده پروفایل

مدرس

• Ecological Genetics
• Evolutionary Biology
• Plant Genetics
• +۳ مورد دیگر

Dr. Anna Feller is a Lecturer at ETH Zürich in the Department of Ecological Plant Genetics. Her research focuses on evolutionary genetics, speciation mechanisms, and the genetic basis of adaptive traits in plants and animals. She investigates reproductive isolation processes, genomic architecture of adaptive radiation, and the role of ecological factors in driving speciation. Her work spans plant species like Phlox and animal models such as cichlid fishes, addressing topics like postzygotic incompatibilities, prezygotic barriers, and sex chromosome evolution. Dr. Feller’s studies emphasize the interplay between genetic variation and ecological adaptation, contributing to our understanding of how new species arise under different selection pressures. Recent publications highlight her exploration of asymmetrical reproductive isolation in Phlox, novel sex chromosomes in cichlids, and the genetic drivers of behavioral novelty in hybrid populations. Her research integrates field observations, experimental genetics, and genomic analyses to unravel complex evolutionary processes.

Monica Andrea Garcia Otaloraمشاهده پروفایل

مدرس

• Taxonomy of rust fungi
• Lichen systematics
• Molecular phylogeny
• +۴ مورد دیگر

Dr. Monica Andrea Garcia Otalora is a Lecturer at the Department of Biology, ETH Zurich, Switzerland. She is affiliated with the Gruppe Biosystematik and coordinates the 'Deep Digitization of Fungi' program at the Zurich Fungarium (Z+ZT). Her research focuses on fungal taxonomy, particularly rust fungi on Solanaceae and lichen-forming Ascomycetes, with an emphasis on Collemataceae. Her work integrates molecular phylogeny, population genetics, and biodiversity informatics to digitize fungal collections and study symbiotic relationships. Education PhD in Biology (2008), Universidad Rey Juan Carlos, Madrid MSc in Botany (2004), Universidad Rey Juan Carlos, Madrid BSc in Microbiology (1999), Universidad de los Andes, Bogotá Research Highlights Leading digitization projects for plant-pathogenic fungi in Swiss herbaria Published catalogues of rust fungi on Solanaceae with 1,400+ images Explored species delimitation in lichen symbionts using multi-locus data Documented invasive South American rust fungi in Europe Labs/Teams She leads the fungal collection curation team at the United Herbaria Zurich (Z+ZT). Her work involves collaboration with institutions like the Swedish Museum of Natural History and the Swiss National Herbarium (B). She teaches the Field Course in Mycology (Spring Semester 2024) at ETH Zurich.

Geng Wangمشاهده پروفایل

پژوهشگر ارشد

• Statistical genetics
• Genetic epidemiology
• Developmental origins of health and disease (DOHaD)
• +۵ مورد دیگر

Dr. Geng Wang is a Postdoctoral Research Fellow at the Institute for Molecular Bioscience , University of Queensland. His research specializes in statistical genetics and genetic epidemiology , focusing on the developmental origins of health and diseases , causal inference in genetic epidemiology , and genetic susceptibility of complex traits . He combines expertise in bioinformatics , clinical research , and statistical genetics with a clinical medicine background and biotechnology industry experience. Bachelor of Medicine (2012), Second Military Medical University, China Master of Internal Medicine (2016), Second Military Medical University, China PhD in Genetics (2023), University of Queensland His research explores intergenerational genetic effects through Mendelian randomization and structural equation modeling , particularly investigating maternal-fetal genetic interactions and HLA contributions to immune-related diseases . Recent publications analyze ankylosing spondylitis across diverse populations and reproductive outcomes like miscarriage and stillbirth. Dr. Wang is available for supervision and maintains active collaborations across University of Queensland and international institutions, with external profiles on ORCID , Google Scholar , and LinkedIn .

Melloni Cookمشاهده پروفایل

استاد

• Genetic Basis of Complex Traits
• Animal Models of Anxiety
• Behavioral Neuroscience
• +۳ مورد دیگر

Melloni Cook, Ph.D., is a Dunavant Professor and Chair of Research Initiatives in the Department of Psychology at the University of Memphis. She directs the Center for Applied Psychological Research and holds affiliations with the Behavioral Neuroscience program. Her academic roles include leadership in research strategy and interdisciplinary collaboration. Dr. Cook earned a B.S. from Mary Washington College and a Ph.D. in Biobehavioral Health from Pennsylvania State University (1996), with dissertation work on region-specific monoamine responses to cocaine. Her research focuses on genetic and neurobiological mechanisms underlying anxiety, stress responses, and addiction-related behaviors using animal models and systems genetics approaches. Key research themes include: Genetic basis of complex traits (e.g., stress-ethanol interactions) Neuropharmacology of fear circuits and dopamine signaling Gene network analysis in alcohol and cocaine use disorders Her work combines molecular biology techniques with behavioral phenotyping, leveraging mouse models to identify candidate genes and molecular pathways. Notable contributions include discoveries about HSPA8 networks in stress responses and serotonin system architecture. Dr. Cook has held prestigious awards including the Dunavant Professorship, recognizing her research excellence. Her lab actively investigates neuroendocrine mechanisms and epigenetic factors in mental health conditions through NIH-funded projects and collaborative initiatives.

• Biostatistics
• Epidemiology
• Medical Statistics
• +۷ مورد دیگر

Professor Liz Holliday is a Professor of Biostatistics at the University of Newcastle, serving as Deputy Head of School (Research) and Head of Discipline (Medical Statistics) within the School of Medicine and Public Health. She holds affiliations with the Data Sciences Support Unit at the Hunter Medical Research Institute. Her expertise spans biostatistics, epidemiology, and clinical trial design, with a focus on medical research excellence. Holliday has a BSc (Hons I) in Mathematics and Molecular Bioscience (2003), a PhD in Genetic Statistics (2008), and a Master of Science in Statistics (2012). Education: Bachelor of Science (Honours), University of Queensland PhD in Genetic Statistics, University of Queensland Master of Science in Statistics, University of Queensland Research Interests: Liz specializes in biostatistics and epidemiology, particularly in randomized controlled trials (fixed/adaptive designs), causal inference for observational studies, life expectancy estimation, generalized linear modeling, and genetic statistics. Her work emphasizes applications in health and medicine, including collaborations on stroke, respiratory diseases, and public health initiatives. Publications & Awards: Co-author of over 340 peer-reviewed articles and six book chapters, Holliday has secured $30 million in research funding. Notable awards include the Star Graduate (2013), Career Development Award (2013), and Young Investigator Travel Award (2011). Her research has advanced statistical methods in medical studies and public health policy. Grants & Collaborations: Holliday leads or collaborates on grants totaling $30 million, focusing on clinical trials, genetic studies, and public health interventions. She advises academic committees and government/industry bodies, emphasizing interdisciplinary research. Labs & Teams: Affiliated with the Data Sciences Support Unit at HMRI, she collaborates with clinical and public health researchers globally, contributing to projects like the Stroke Genetics Consortium and respiratory disease studies.

• Statistical Genetics
• Genome-Wide Association Study
• Blood Pressure
• +۲ مورد دیگر

Andrew Morris is Professor of Statistical Genetics in the Division of Musculoskeletal & Dermatological Sciences at the University of Manchester. His research focuses on genetic determinants of complex diseases using large-scale genomic approaches. He leads projects investigating blood pressure regulation, type 2 diabetes heterogeneity, and cross-ancestry genetic imputation methods. Research interests center on statistical genetics methodologies including genome-wide association studies (GWAS), genetic risk prediction, and multi-omics integration. His work bridges computational biology and clinical applications in cardiometabolic diseases. Recent publications demonstrate strong focus on transcriptome analysis, polygenic risk scoring, and identifying novel therapeutic targets for hypertension and diabetes through integrative genomics. Active in major collaborative initiatives including the BHF Centre for Research Excellence 2024-2029 and NIHR Manchester Biomedical Research Centre.